OpenFilings

Aurinia Pharmaceuticals Inc.

Form10-K/A

Report Period2023-12-31

Date Filed2024-04-29

Time Filed16:14:13

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
EX-31.2
EX-31.3
Filing on SEC Edgar